Embed Size (px)
Citation preview
DIRECTOR
Luís CostaHospital de Santa Maria, Lisbon, Portugal
CO-DIRECTOR
Miguel Martín Hospital General Universitario Gregorio Marañón, Madrid, Spain
FORMATVIRTUAL
L I S B O N E D I T I O NOctober 2021(WEST) Western European Summer Time
www.innovationinbreastcancer.com/lisbon
www.innovationinbreastcancer.com/lisbon
(WEST) Western European Summer Time
14 October 2021THURSDAY 15 October 2021FRIDAY
FORMATVIRTUAL
L I S B O N E D I T I O N
16:00 - 16:15 Opening remarks Luís Costa, Hospital de Santa Maria, Lisbon, Portugal
16:15 - 17:25 SESSION I PERSONALIZED SCREENING AND PERSONALIZED PREVENTIONChairs: Fá�ma Vaz, Portuguese Ins�tute of Oncology, Lisbon, Portugal Teresa Ramón y Cajal, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
16:15 - 16:35 Breast cancer screening and preven�on in women with germinal deleterious muta�on Angela George, Royal Marsden Hospital, London, UK
16:35 - 16:55 Breast cancer screening and secondary preven�on in women with past history of breast cancer Faina Nakhlis, Harvard Medical School, Boston, USA
16:55 - 17:25 Discussion
17:25 - 17:40 Break
17:40 - 19:10 SESSION II ADJUVANT THERAPY IN BREAST CANCER: DEBATING AND EVOLVING Chairs: José Luís Passos Coelho, Hospital da Luz, Lisbon, Portugal Ángel Guerrero, Valencia Oncology Ins�tute Founda�on, Spain
17:40 - 18:00 Ki67 and genomic pla�orms Fernando Schmi�, University of Porto, Portugal
18:00 - 18:20 Genomics to support decision on adjuvant therapy Emilio Alba, Hospital Clínico Univ. Virgen de la Victoria, Málaga, Spain
18:20 - 18:40 Adjuvant post-neoadjuvant Edith A. Perez, Mayo Clinic, Florida, USA
18:40 - 19:10 Discussion
16:00 - 17:00 SESSION III HER2 BREAST CANCERChairs: Miguel Mar�n, Hospital General Universitario Gregorio Marañón, Madrid, Spain Luís Costa, Hospital de Santa Maria, Lisbon, Portugal
16:00 - 16:20 Brain metastases: what is new? Nancy U. Lin, Harvard Medical School, Boston, USA
16:20 - 16:40 Long-term responders to double blockade: what is next? Sandra Swain, Georgetown University School of Medicine, Washington, USA
16:40 - 17:00 Discussion
17:00 - 17:40 KEYNOTE LECTURE
17:00 - 17:30 Tumor microenvironment dynamics in breast cancer during neo-adjuvant chemotherapy Carlos Caldas, Cambridge Breast Cancer Research Unit, UK
17:30 - 17:40 Discussion
17:40 - 17:55 Break
17:55 - 19:05 SESSION IV LUMINAL A BREAST CANCER Chair: Evandro Azambuja, Ins�tut Jules Bordet, Brussels, Belgium
17:55 - 18:15 Why do CDKis are effec�ve in luminal A? Richard Finn, University of California, Los Angeles, USA
18:15 - 18:35 Endpoints during CDKis therapy: clinicians and pa�ent’s perspec�ves Miguel Mar�n, Hospital General Universitario Gregorio Marañón, Madrid, Spain
18:35 - 19:05 Discussion
19:05 - 19:20 Closing remarks Luís Costa, Hospital de Santa Maria, Lisbon, Portugal
www.innovationinbreastcancer.com/lisbon
Organized by
Accreditation
Under the auspices ofSponsors
Gold
Other collaborationsTel.: (+351) 912 417 887e-mail: [email protected]/lisbon
Silver
Bronze
Platinum
The Innova�on in Breast Cancer symposium - Lisbon edi�on (IBC Lisbon 2021), Online, Portugal, 14/10/2021-15/10/2021 has been accredited by the European Accredita�on Council for Con�nuing Medical Educa�on (EACCME®) with 4 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educa�onal ac�vity.
![[MS-VHDX]: Virtual Hard Disk v2 (VHDX) File Format...The virtual hard disk v2 (VHDX) file format provides features at the virtual hard disk as well as virtual hard disk file layers](https://img.pdfslide.us/doc/110x75/5f0644ed7e708231d417253b/ms-vhdx-virtual-hard-disk-v2-vhdx-file-format-the-virtual-hard-disk-v2.jpg)
